Ontology highlight
ABSTRACT: Significance
Stemness is a hallmark of many cancers and is largely responsible for disease emergence, progression, and relapse. Our finding that clinically significant stemness programs in AML are directly regulated by different stoichiometries of cytokine receptors represents a hitherto unexplained mechanism underlying cell-fate decisions in cancer stem cell hierarchies. This article is highlighted in the In This Issue feature, p. 1749.
SUBMITTER: Kan WL
PROVIDER: S-EPMC10401075 | biostudies-literature | 2023 Aug
REPOSITORIES: biostudies-literature
Kan Winnie L WL Dhagat Urmi U Kaufmann Kerstin B KB Hercus Timothy R TR Nero Tracy L TL Zeng Andy G X AGX Toubia John J Barry Emma F EF Broughton Sophie E SE Gomez Guillermo A GA Benard Brooks A BA Dottore Mara M Cheung Tung Shing Karen S KS Boutzen Héléna H Samaraweera Saumya E SE Simpson Kaylene J KJ Jin Liqing L Goodall Gregory J GJ Begley C Glenn CG Thomas Daniel D Ekert Paul G PG Tvorogov Denis D D'Andrea Richard J RJ Dick John E JE Parker Michael W MW Lopez Angel F AF
Cancer discovery 20230801 8
Leukemia stem cells (LSC) possess distinct self-renewal and arrested differentiation properties that are responsible for disease emergence, therapy failure, and recurrence in acute myeloid leukemia (AML). Despite AML displaying extensive biological and clinical heterogeneity, LSC with high interleukin-3 receptor (IL3R) levels are a constant yet puzzling feature, as this receptor lacks tyrosine kinase activity. Here, we show that the heterodimeric IL3Rα/βc receptor assembles into hexamers and dod ...[more]